The Latest Cardiac and Vascular News
With its newly-approved CE Mark, Denver-based company HeartHero is poised on the front lines to combat the global threat of Cardiac Death. Created by a team of medical experts and partners, Elliot’s affordable price tag and portable size help place lifesaving technology within arm’s reach for anyone, anywhere. DENVER–(BUSINESS WIRE)–Today, […]
ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures with RapidAI, a company that offers a clinically proven, data-driven artificial intelligence (AI) platform […]
Transaction forms new platform company to build a leading consolidator of outpatient cardiology, cardiovascular practices and cardiac catheterization facilities LOS ANGELES & STAMFORD, Conn.–(BUSINESS WIRE)–Varsity Healthcare Partners (“VHP”), a leading healthcare services private equity investment firm, announced today a growth equity investment with Partners First Cardiology (“Partners First”, “PFC”, or […]
SANTA CLARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended September 30, 2020. Recent Highlights Recognized revenue of $19.6 million […]
WAYNE, N.J. and BE’ER SHEVA, Israel, Nov. 10, 2020 (GLOBE NEWSWIRE) — Konica Minolta Healthcare Americas, Inc., and DiA Imaging Analysis Ltd. jointly announce the expanded deployment of the LVivo Cardiac ultrasound artificial intelligence (AI) Toolbox on the Exa® Cardio PACS platform. Exa users will have access to LVivo Toolbox to […]
EDEN PRAIRIE, Minn., Nov. 10, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the third quarter ended September 30, 2020. Recent Highlights Revenue for the third quarter of 2020 was $1.9 million, an increase of 52% compared to the prior year period Increased Aquadex™ […]
SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and business highlights for the third quarter of 2020 and filed its quarterly report on Form 10-Q for the three and nine months ended […]
ZURICH, November 10, 2020 / PRNewswire / – Concept Medical Inc., a company focused on medical devices for drug delivery in vascular interventions, announced the enrollment of the first patient in the SirPAD clinical study ( Sir olimus in P eripheral A rtery D isease) (Sirolimus in peripheral arterial disease). The SirPAD is the first randomized controlled clinical trial and for all who […]
CARLSBAD, Calif., Nov. 10, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that accomplished Ionis scientists will highlight the company’s pioneering advancements in research and drug development in antisense technology during the RNA at the Bench and Bedside II Conference, to be held virtually Nov. 11-13, 2020. Plenary session presentations will include a review of […]
Twelve-Month Results Presented Today in Late-Breaking Trials Session at Vascular Interventional Advances (VIVA) Conference PARIS–(BUSINESS WIRE)–LimFlow SA, the pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced the presentation of 12-month data from the […]
